Cancer-killing treatment using a common cold virus offers hope to patients with inoperable tumors
Cancer-killing treatment using a COMMON COLD virus could give hope to patients with inoperable tumors Phase I clinical trial announced Friday was conducted at NYU Langone Health Used a combination of a live cold virus with an immunotherapy drug Treatment shrank melanoma tumors in 47% of the trial’s 36 participants Several studies have examined how oncolytic viruses … Read more